US 11142766
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61P
Quick answer
US patent 11142766 (Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/713, A61P, A61P1/16, A61P1/18